CookiesThis site uses cookies to analyze site interaction in order to improve the quality of service and ensure smooth operation of the site. In more detail in Cookies policy
A specialized edition intended for medical institutions and doctors.

Calcium gluconate-Darnitsa

Release forms:
Hypoparathyroidism; increased calcium excretion from the body (especially during prolonged dehydration); as an adjuvant treatment in allergic diseases (serum sickness, urticaria, angioedema) and allergic complications of drug therapy; to reduce vascular permeability in pathological processes of any genesis (exudative phase of the inflammatory process, haemorrhagic vasculitis, radiation sickness); parenchymal hepatitis; toxic liver damage; nephritis; eclampsia; hyperkalemia; hyperkalemic paroxysmal myoplegia; skin diseases (pruritis, eczema, psoriasis); as a haemostatic agent; as an antidote in poisoning with magnesium salts, oxalic acid or its soluble salts, soluble fluoric acid salts.
Characteristics of the productу:
    • Release formInjectable solution
    • ChildrenAllowed from 14 years
    • PregnantWith caution
    • NursingWith caution
    • Release categoryPrescription medication
    • AllergicsAllowed
    • Temperature storage conditionsNot higher than 25 °С
    • Qualitative and quantitative composition
    • Pharmaceutical form
    • Pharmacotherapeutic group
    • Pharmacological properties.
    • Clinical particulars
    • Therapeutic indications.
    • Contraindications.
    • Interaction with other medicinal products and other forms of interaction
    • Special warnings and precautions for use
    • Posology and method of administration
    • Overdose.
    • Undesirable effects.
    • Shelf life.
    • Special precautions for storage
    • Incompatibilities
    • Nature and contents of container
    • Category of release
    • Manufacturer
    • The manufacturer's location and address of the place of business
    • Date of last revision